NATURE’S SUNSHINE PRODUCTS, INC. Line of Credit, Current
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Line of Credit, Current of $0 as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2017-11-09
- 2017-09-30: Line of Credit, Current $0.00.
- 2017-06-30: Line of Credit, Current $11.95M.
- 2017-03-31: Line of Credit, Current $13.26M.
- 2016-12-31: Line of Credit, Current $9.92M.
| Period end | Line of Credit, Current |
|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $11.95M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $13.26M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $9.92M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $9.01M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.92M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $7.53M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $2.70M 10-Q · filed 2016-11-09 |
| 2015-09-30 | $1.20M 10-Q · filed 2015-11-06 |
| 2015-03-31 | $348.00K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |